Harmony Biosciences Holdings Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Harmony Biosciences Holdings Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: Plymouth Meeting
Headquarters state / province: Pennsylvania
Headquarters country: United States
Fiscal year end: December
Ticker symbol: HRMY
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001802665
EIN: 82-2279923

Board of directors

Follow this board

Antonio J. Gracias · Director
Since 2023
Gary Sender · Director
Since 2023
Geno J. Germano · Director
Since 2026
Jack Nielsen · Director
Since 2023
Jeffrey M. Dayno · Director · PRESIDENT, CEO
Since 2023
Juan A. Sabater · Director
Since 2023
Linda M. Szyper · Director
Since 2023
Peter Anastasiou · Director
Since 2023
R. Mark Graf · Director
Since 2023
Ron M. Philip · Director
Since 2025
Troy A. Ignelzi · Director
Since 2026

Chief executives

Jeffrey M. Dayno · PRESIDENT, CEO

Dates unknown

Director election results

Annual meeting of May 14, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

7 of this board's directors also sit on 15 other boards. 12 are in the same sector.

Shared director Other board Same sector

ALX Oncology Holdings Inc. Same sector
via Jack Nielsen
Aligos Therapeutics Inc. Same sector
via Jack Nielsen
Apnimed Inc. Same sector
via Gary Sender
Avalo Therapeutics Inc. Same sector
via Ron M. Philip
City Therapeutics Inc. Same sector
via Ron M. Philip
Contineum Therapeutics Inc. Same sector
via Troy A. Ignelzi
Eloxx Pharmaceuticals Inc. Same sector
via Geno J. Germano
Entera Bio Ltd. Same sector
via Geno J. Germano
Instil Bio Inc. Same sector
via Jack Nielsen
Marqeta Inc.
via R. Mark Graf
Precision BioSciences Inc. Same sector
via Geno J. Germano
Schrodinger Inc. Same sector
via Gary Sender
Signet Jewelers Limited
via R. Mark Graf
Space Exploration Technologies Corp.
via Antonio J. Gracias
iBio Inc. Same sector
via Gary Sender

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $5,951,370; 13 sales by 3 insiders

Date	Insider	Transaction	Shares	Price	Value
Sep 18, 2026	Budur Kumar Officer (CHIEF MEDICAL OFFICER)	Option exercise	+10,406	$30.69	$319,360
Sep 18, 2026	Budur Kumar Officer (CHIEF MEDICAL OFFICER)	Option exercise	+25,446	$30.27	$770,250
Sep 18, 2026	Budur Kumar Officer (CHIEF MEDICAL OFFICER)	Open-market sale	−35,852	$43.05	$1,543,429
Sep 17, 2026	Budur Kumar Officer (CHIEF MEDICAL OFFICER)	Option exercise	+400	$30.69	$12,276
Sep 17, 2026	Budur Kumar Officer (CHIEF MEDICAL OFFICER)	Option exercise	+400	$30.27	$12,108
Sep 17, 2026	Budur Kumar Officer (CHIEF MEDICAL OFFICER)	Open-market sale	−800	$43.00	$34,400
Sep 16, 2026	Budur Kumar Officer (CHIEF MEDICAL OFFICER)	Option exercise	+900	$30.69	$27,621
Sep 16, 2026	Budur Kumar Officer (CHIEF MEDICAL OFFICER)	Option exercise	+900	$30.27	$27,243
Sep 16, 2026	Budur Kumar Officer (CHIEF MEDICAL OFFICER)	Open-market sale	−1,800	$43.01	$77,418
Sep 8, 2026	Budur Kumar Officer (CHIEF MEDICAL OFFICER)	Open-market sale	−4,500	$42.25	$190,125
Sep 8, 2026	Budur Kumar Officer (CHIEF MEDICAL OFFICER)	Open-market sale	−1,000	$42.79	$42,790
Sep 8, 2026	Budur Kumar Officer (CHIEF MEDICAL OFFICER)	Option exercise	+12,200	$30.69	$374,418
Sep 8, 2026	Budur Kumar Officer (CHIEF MEDICAL OFFICER)	Option exercise	+10,754	$30.27	$325,524
Sep 8, 2026	Budur Kumar Officer (CHIEF MEDICAL OFFICER)	Open-market sale	−22,954	$43.10	$989,317
Sep 4, 2026	Budur Kumar Officer (CHIEF MEDICAL OFFICER)	Open-market sale	−5,500	$41.98	$230,890

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Harmony Biosciences Holdings Inc.

Who is the CEO of Harmony Biosciences Holdings Inc.?

Jeffrey M. Dayno is Harmony Biosciences Holdings Inc.'s PRESIDENT, CEO.

How many directors are on Harmony Biosciences Holdings Inc.'s board?

Harmony Biosciences Holdings Inc.'s board has 11 directors: Antonio J. Gracias, Gary Sender, Geno J. Germano, Jack Nielsen, Jeffrey M. Dayno, Juan A. Sabater, Linda M. Szyper, Peter Anastasiou, R. Mark Graf, Ron M. Philip and 1 other.

Are Harmony Biosciences Holdings Inc. insiders buying or selling shares?

Over the last 12 months, Harmony Biosciences Holdings Inc. insiders made no open-market purchases and sold $6.0 million of shares in 13 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Harmony Biosciences Holdings Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="harmony-biosciences-holdings-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.